U.S. Insulin Patch Pumps Market Size & Outlook, 2023-2030
U.S. insulin patch pumps market, 2018-2030 (US$M)
Related Markets
U.S. insulin patch pumps market highlights
- The U.S. insulin patch pumps market generated a revenue of USD 316.8 million in 2023 and is expected to reach USD 618.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10% from 2024 to 2030.
- In terms of segment, basal and bolus was the largest revenue generating delviery mode in 2023.
- Basal and Bolus is the most lucrative delviery mode segment registering the fastest growth during the forecast period.
Insulin patch pumps market data book summary
| Market revenue in 2023 | USD 316.8 million |
| Market revenue in 2030 | USD 618.8 million |
| Growth rate | 10% (CAGR from 2023 to 2030) |
| Largest segment | Basal and bolus |
| Fastest growing segment | Basal and Bolus |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Basal, Bolus, Basal and Bolus |
| Key market players worldwide | Medtronic PLC, Roche Holding AG, Insulet Corp, Terumo Corp, Tandem Diabetes Care Inc, CeQur Simplicity, Medtrum, Debiotech |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.7% of the global insulin patch pumps market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. insulin patch pumps market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 146.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Patch Pumps Market Scope
Insulin Patch Pumps Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. insulin patch pumps market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin patch pumps market will help companies and investors design strategic landscapes.
Basal and bolus was the largest segment with a revenue share of 56.38% in 2023. Horizon Databook has segmented the U.S. insulin patch pumps market based on basal, bolus, basal and bolus covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the U.S. dominated the market owing to a large diabetic population and favorable reimbursement policies. High per capita income and increasing healthcare spending are among the other key factors expected to drive the region’s market.
According to the American Diabetes Association, total cost of diagnosed diabetes in 2017 was USD 327 billion. In the U.S., people with diagnosed diabetes incur an average medical expenditure of USD 16,750 per year.
Furthermore, adoption of smart devices and technological advancements, such as AI & data analytics, are likely to propel the market. According to the International Diabetes Federation, one in six U.S. adults has impaired blood glucose tolerance, which is the highest of all regions.
Reasons to subscribe to U.S. insulin patch pumps market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. insulin patch pumps market databook
-
Our clientele includes a mix of insulin patch pumps market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. insulin patch pumps market , including forecasts for subscribers. This country databook contains high-level insights into U.S. insulin patch pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. insulin patch pumps market size, by delviery mode, 2018-2030 (US$M)
U.S. Insulin Patch Pumps Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
